Jul. 21 at 3:12 PM
$FITY The FDA’s Pharmacy Compounding Advisory Committee (PCAC) is meeting on July 23–24, 2026, at the FDA White Oak Campus in Silver Spring, Maryland. The panel will review seven specific peptides to determine if they should be added to the 503A Bulk Drug Substances list, which would allow compounding pharmacies to legally prepare them